Heng M. Mei

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 206 publications

Correlation of per- and polyfluoroalkyl substances exposure with gestational age acceleration and birth outcomes in monozygotic twins

Correlation of per- and polyfluoroalkyl substances exposure with gestational age acceleration and birth outcomes in monozygotic twins

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: June 29, 2026

Current status and progress of prognostic evaluation in marginal zone lymphoma

Current status and progress of prognostic evaluation in marginal zone lymphoma

Journal: Zhonghua yi xue za zhi

Published: June 15, 2026

BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia.

BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia.

Journal: Blood

Published: May 28, 2026

BMSCs-AML cell interaction drives FLT3 inhibitor resistance through the NR2F2/COX-2/PGE2 Axis.

BMSCs-AML cell interaction drives FLT3 inhibitor resistance through the NR2F2/COX-2/PGE2 Axis.

Journal: Cellular signalling

Published: May 14, 2026

The application of thrombopoietin receptor agonists in the treatment of non-muscle myosin heavy chain 9-related disease

The application of thrombopoietin receptor agonists in the treatment of non-muscle myosin heavy chain 9-related disease

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: April 16, 2026

Machine Learning-Based Prediction of Mononuclear Cell Collection Efficiency for CAR-T Manufacturing.

Machine Learning-Based Prediction of Mononuclear Cell Collection Efficiency for CAR-T Manufacturing.

Journal: Current medical science

Published: April 01, 2026

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Journal: American journal of hematology

Published: March 09, 2026

A proactive large platelet-driven screening strategy for the early recognition of MYH9-related disease: a Chinese prospective cohort study.

A proactive large platelet-driven screening strategy for the early recognition of MYH9-related disease: a Chinese prospective cohort study.

Journal: Research and practice in thrombosis and haemostasis

Published: February 16, 2026

Belumosudil for acute GVHD after allogeneic hematopoietic stem cell transplantation: a retrospective case series.

Belumosudil for acute GVHD after allogeneic hematopoietic stem cell transplantation: a retrospective case series.

Journal: International journal of hematology

Published: February 13, 2026

High IL-10 levels during CRS are negatively associated with NK-cell recovery after CAR-T cell therapy.

High IL-10 levels during CRS are negatively associated with NK-cell recovery after CAR-T cell therapy.

Journal: Clinical & translational immunology

Published: February 12, 2026

Subsequent CAR-T and engineered antibody for relapsed/refractory multiple myeloma following BCMA-targeted treatment: a systematic review and meta-analysis.

Subsequent CAR-T and engineered antibody for relapsed/refractory multiple myeloma following BCMA-targeted treatment: a systematic review and meta-analysis.

Journal: Blood cancer journal

Published: January 31, 2026

Crosstalk between cytokines and tryptophan metabolism: Therapeutic potential for immune effector cell-associated neurotoxicity syndrome.

Crosstalk between cytokines and tryptophan metabolism: Therapeutic potential for immune effector cell-associated neurotoxicity syndrome.

Journal: Biochemical pharmacology

Published: December 26, 2025

Showing 1-12 of 206

Last Updated: 09/26/2026